Dihydromyricetin affect the pharmacokinetics of triptolide in rats

References

• Beglyarova N, Banina E, Zhou Y, et al. (2016). Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer. Clin Cancer Res 22:6153–63.
   PubMed Web of Science ®Google Scholar
• Beyer J, Rick O, Weinknecht S, et al. (1997). Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome. Bone Marrow Transplant 20:813–9.
   PubMed Web of Science ®Google Scholar
• Borja-Cacho D, Yokoyama Y, Chugh RK, et al. (2010). TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells. J Gastrointest Surg 14:252–60.
   PubMed Web of Science ®Google Scholar
• Cao LJ, Yan M, Ma YX, et al. (2016). Isoliquiritigenin protects against triptolide-induced hepatotoxicity in mice through Nrf2 activation. Pharmazie 71: 394–7.
   PubMed Web of Science ®Google Scholar
• Chen BJ. (2001). Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma 42:253–65.
   PubMed Web of Science ®Google Scholar
• Du JL, Cui MH, Su ZW, et al. (2008). Effects of compatibility of Tripterygium wilfordii Hook. and licorice on biochemical parameters in rats. J Pract Tradit Chin Intern Medi 22:71–2.
   Google Scholar
• Gong XM, Chen Y, Wu Y. (2015). Absorption and metabolism characteristics of triptolide as determined by a sensitive and reliable LC-MS/MS method. Molecules 20:8928–40.
   PubMed Web of Science ®Google Scholar
• Han D, Lerner AG, Vande Walle L, et al. (2009). IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 138:562–75.
   PubMed Web of Science ®Google Scholar
• He GX, Pei G, Zhou TD, Zhou XX. (2000). Determination of total flavonoids and dihydromyricetin in the ampelopsis grossedentata. Chin J Chin Mater Med 25:39–41.
   Google Scholar
• Ho LJ, Chang DM, Chang ML, et al. (1999). Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J Rheumatol 26:14–24.
   PubMed Web of Science ®Google Scholar
• Hou XL, Tong Q, Wang WQ, et al. (2015). Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways. Life Sci 130:38–46.
   PubMed Web of Science ®Google Scholar
• Huang HL, Hu M, Zhao R, et al. (2013). Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway. Oncol Rep 30:2467–75.
   PubMed Web of Science ®Google Scholar
• Jia YZ, Liu J, Xu JS. (2018). Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide. Xenobiotica 48:407–11.
   PubMed Web of Science ®Google Scholar
• Kupchan SM, Court WA, Dailey RG, Jr, et al. (1972). Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc 94:7194–5.
   PubMed Web of Science ®Google Scholar
• Li XJ, Jiang ZZ, Zhang LY. (2014). Triptolide: progress on research in pharmacodynamics and toxicology. J Ethnopharmacol 155:67–79.
   PubMed Web of Science ®Google Scholar
• Li ZH, Yan M, Cao LJ, et al. (2017). Glycyrrhetinic acid accelerates the clearance of triptolide through P-gp in vitro. Phytother Res 31:1090–6.
   PubMed Web of Science ®Google Scholar
• Li YS, Tong PJ, Ma HZ, et al. (2006). The attenuating and synergistic effect of licorice on the treatment of rheumatoid arthritis with Tripterygium wilfordii. Chin J Integr Tradit West Med 26:1117–9.
   Google Scholar
• Liu Q. (2011). Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol 11:377–83.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xiao E, Yuan L, Li G. (2014). Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo. DNA Cell Biol 33:418–25.
   PubMed Web of Science ®Google Scholar
• Liu JQ, Hong Q, Zhang W, et al. (2010). The attenuating effect of phoenix on triptolide. Chin Hosp Pharm J 30:443–6.
   Google Scholar
• Matsui Y, Watanabe J, Ikegawa M, et al. (2008). Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. Oncogene 27:4603–14.
   PubMed Web of Science ®Google Scholar
• Menicagli S, Lippi A, Criscuoli M, Gervasi PG. (1993). Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes. Biochem Pharmacol 45:1097–105.
   PubMed Web of Science ®Google Scholar
• Murakami T, Miyakoshi M, Araho D, et al. (2004). Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors 21:175–8.
   PubMed Web of Science ®Google Scholar
• Oh GS, Kim HJ, Shen A, et al. (2014). Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press 12:55–65.
   PubMedGoogle Scholar
• Qi S, Xin Y, Guo Y, et al. (2012). Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol 12:278–87.
   PubMed Web of Science ®Google Scholar
• Reno TA, Tong SW, Wu J, et al. (2016). The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer. BMC Cancer 16:439.
   PubMed Web of Science ®Google Scholar
• Sun YT, Liu W, Wang CY, et al. (2019). Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: a new strategy of inhibiting P-glycoprotein. J Cell Physiol 234:3685–96.
   PubMed Web of Science ®Google Scholar
• Sun YT, Wang CY, Meng Q, et al. (2018). Targeting P-glycoprotein and SORCIN: dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca(2+) -mediated apoptosis pathways in MCF-7/ADR and K562/ADR. J Cell Physiol 233:3066–79.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Sun XT, Feng YY, et al. (2017a). Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells. Anticancer Drugs 28:281–8.
   PubMed Web of Science ®Google Scholar
• Wang XM, Zhang X, Liu F, et al. (2017b). The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism. Pharm Biol 55:1863–7.
   PubMed Web of Science ®Google Scholar
• Wen HL, Liang ZS, Zhang R, Yang K. (2013). Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovasc Diabetol 12:50.
   PubMed Web of Science ®Google Scholar
• Wu B, Lin J, Luo J, et al. (2017). Dihydromyricetin protects against diabetic cardiomyopathy in streptozotocin-induced diabetic mice. Biomed Res Int 2017:3764370.
   PubMedGoogle Scholar
• Zhang WY, Kang M, Zhang TT, et al. (2016a). Triptolide combined with radiotherapy for the treatment of nasopharyngeal Carcinoma via NF-kappaB-related mechanism. Int J Mol Sci 17:2139.
   Web of Science ®Google Scholar
• Zhang YC, Li J, Lei XL, et al. (2016b). Influence of verapamil on pharmacokinetics of triptolide in rats. Eur J Drug Metab Pharmacokinet 41:449–56.
   PubMed Web of Science ®Google Scholar
• Zhang XF, Liu J, Ye F, et al. (2014). Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: a possible role of cytochrome P3A4 inhibition. Chin J Integr Med 20:534–9.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou YL, Liu W. (2005). The clinical efficacy of the synergism and attenuation of total glucosides of paeony combined with tripterygium glycosides in the treatment of rheumatoid arthritis was observed. Tianjin J Tradit Chin Med 22:207–8.
   Google Scholar
• Zhou ZL, Yang YX, Ding J, et al. (2012). Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms. Nat Prod Rep 29:457–75.
   PubMed Web of Science ®Google Scholar